Biotechnology feeling the BernIn light of the recent selloff in many of the gummie favorites, I am looking to hear from some of our distinguished members regarding their thoughts on the impacts of the coming elections as it pertains to biotech. It has been a bumpy ride for over a year and with so much discussion taking place about the evil biotech/pharma screwing the little guy and how they need to be reigned in…..well, I would like to receive some reasoned thinking from our group if they are willing to chime in.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I think right now, as Trump is imploding, the market thinks he may take down the entire republican party with him. The perception is with Hillary in office and the Dems in control of both houses of Congress, substantial drug pricing regulation is not far behind.
I do not see it happening. The House seems out of reach for the Dems. A party needs 218 seats for control. 206 are Red safe and another 10 are highly likely Red. Another 10 are leaning Red and 14 are toss-up right now. The Repubs only need to win 4 of the 24 that are toss-ups or leaning Red. I would not concede the Senate either.
I am using this sell-off as a buying opportunity. I have cut back significantly in my minerals holdings to purchase more of those that IMO, have fallen well below value: $SCYX; $AKAO, $BIOC, $TGTX and $PTLA
Mich – Thanks for your perspective. I hope you are right although it appears to me that the house may also be in jeopardy of Dem control.